Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD1 | Q9Y239 | 5/20 | 0.52 |
| ▸ | GSR | P00390 | 1/20 | 0.52 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.51 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.51 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.51 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.51 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.51 |
| ▸ | DDAH1 | O94760 | 2/20 | 0.49 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.49 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.49 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.49 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.49 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.47 |
| ▸ | ARG1 | P05089 | 3/20 | 0.47 |
| ▸ | ARG2 | P78540 | 3/20 | 0.47 |
| ▸ | NOS1 | P29475 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10286387 | 1.00 | NOD1 (0.52) | NOD1GSRGRIK1GRIK2SLC1A2 | |
| SCHEMBL460141 | 0.96 | GRIK1 (0.56) | NOD1GSRGRIK1GRIK2SLC1A2 | |
| SCHEMBL9362560 | 0.96 | GRIK1 (0.56) | NOD1GSRGRIK1GRIK2SLC1A2 | |
| SCHEMBL10615527 | 0.95 | GRIK1 (0.57) | NOD1GSRGRIK1GRIK2SLC1A2 | |
| SCHEMBL4385896 | 0.95 | GRIK1 (0.57) | NOD1GSRGRIK1GRIK2SLC1A2 | |
| SCHEMBL10286393 | 0.94 | NOD1 (0.51) | NOD1GSRGRIK1GRIK2SLC1A2 | |
| SCHEMBL10286394 | 0.94 | NOD1 (0.51) | NOD1GSRGRIK1GRIK2SLC1A2 | |
| SCHEMBL27608418 | 0.93 | GRIK1 (0.56) | NOD1GSRGRIK1GRIK2SLC1A2 | |
| SCHEMBL28032333 | 0.93 | GRIK1 (0.56) | NOD1GSRGRIK1GRIK2SLC1A2 | |
| SCHEMBL25227671 | 0.93 | GSR (0.52) | NOD1GSRGRIK1GRIK2SLC1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120077781-A1 | FLAVIN DERIVATIVES | GADWOOD ROBERT (US) | 2012-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120077781-A1 | FLAVIN DERIVATIVES | BLVRB, FLAD1, FDPS | NOD1 102/4885GSR 587/4885GRIK1 4149/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.